Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Verity Pharmaceuticals
Verity Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Trelstar
Triptorelin pamoate
2000-06-15
2029
Prostatic neoplasms
Tlando
Testosterone undecanoate
2022-03-28
2026-2041
Breast neoplasms
,
Hypogonadism
,
Delayed puberty
,
Prostatic neoplasms
,
Menorrhagia
,
Primary ovarian insufficiency
,
Hot flashes
,
Premature menopause
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Antithrombin iii
anemia
,
iron-deficiency anemia
,
iron deficiencies
,
deficiency diseases
,
chronic renal insufficiency
,
kidney diseases
Sodium chloride
graft rejection
Nepidermin
carcinoma
,
triple negative breast neoplasms
,
squamous cell carcinoma of head and neck
,
neoplasms
,
colorectal neoplasms
,
breast neoplasms
,
ovarian neoplasms
,
pancreatic ductal carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
adenocarcinoma
,
squamous cell carcinoma
,
biliary tract neoplasms
,
esophageal squamous cell carcinoma
,
ovarian epithelial carcinoma
,
glioblastoma
,
non-small-cell lung carcinoma
,
gliosarcoma
,
lung neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use